Abbott Laboratories (Chicago, IL) currently leads the market in pain-free glucose monitoring, Crain’s Chicago Business reports. Abbott offers the FreeStyle Libre, which measures glucose via a sensor without fingersticks. According to Crain’s, Abbott’s device has more than 1.3 million users worldwide and posted 37% sales growth to $1.9 billion in 2018.
Dexcom (San Diego, CA) and Medtronic (Minneapolis, MN) also offer pain-free monitors. The latest Dexcom device, the G6 CGM, warns users of an urgently low or high level of glucose minutes before it hits. Data can also be shared with others through smart devices, for example, with parents who would like to be able to know about dangerously low glucose levels in their children.
According to the Business Wire, the new report “Blood Glucose Monitoring Devices Market—Global Outlook and Forecast 2019–2024” forecasts market revenues of more than $25 billion by 2024. Conventional devices like self-blood glucose testing (with fingersticks) still represented two-thirds of the total market in 2018.
